Publicacións (190) Publicacións nas que participase algún/ha investigador/a

2024

  1. A prospective European trial comparing laparotomy, laparoscopy, robotic-assisted, and transanal total mesorectal excision procedures in high-risk patients with rectal cancer: the RESET trial

    Annals of Surgery

  2. Bilateral Uveal Melanoma: An Insight into Genetic Predisposition in Four New Unrelated Patients and Review of Published Cases

    Journal of Clinical Medicine, Vol. 13, Núm. 11

  3. Clinical Advantages and Limitations of Tumors Displaying Minimal and Extensive Vascular Invasion

    Thyroid FNA Cytology: Differential Diagnoses and Pitfalls, Third Edition (Springer Nature), pp. 119-130

  4. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  5. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  6. Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review)

    Oncology reports, Vol. 52, Núm. 3

  7. The activity of therapeutic molecular cluster Ag5 is dependent on oxygen level and HIF-1 mediated signalling

    Redox Biology, Vol. 76

  8. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors)

    Virchows Archiv, Vol. 482, Núm. 3, pp. 615-623

  2. Expert consensus on the integrated diagnosis of idiopathic multicentric Castleman disease

    Revista Espanola de Patologia, Vol. 56, Núm. 3, pp. 158-167

  3. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study

    British Journal of Haematology, Vol. 203, Núm. 2, pp. 182-193

  4. Should we suspect primary aldosteronism in patients with hypokalaemic rhabdomyolysis? A systematic review

    Frontiers in Endocrinology, Vol. 14

  5. Targets, Mechanisms and Cytotoxicity of Half-Sandwich Ir(III) Complexes Are Modulated by Structural Modifications on the Benzazole Ancillary Ligand

    Cancers, Vol. 15, Núm. 1

  6. “Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study”

    European Journal of Surgical Oncology, Vol. 49, Núm. 10

2022

  1. Adrenal Medullary Hyperplasia: An Under the Radar Cause of Endocrine Hypertension

    American Journal of the Medical Sciences, Vol. 363, Núm. 1, pp. 64-68

  2. Changes and Perspectives in the New 2022 WHO Classification of Thyroid Neoplasms

    Revista Espanola de Patologia

  3. Histopathological Features of Pendred Syndrome Thyroids Align with Differences in the Expression of Thyroid-Specific Markers, Apical Iodide Transporters, and Ciliogenesis Process

    Endocrine Pathology, Vol. 33, Núm. 4, pp. 484-493

  4. Lipoma de Mesocolon: A propósito de un caso

    Revista de Cirugía de Galicia, Vol. 6, Núm. 7

  5. Occludin and claudin-1 are potential prognostic biomarkers in patients with oral squamous cell carcinomas: An observational study

    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Vol. 134, Núm. 5, pp. 588-598

  6. Silver Clusters of Five Atoms as Highly Selective Antitumoral Agents Through Irreversible Oxidation of Thiols

    Advanced Functional Materials, Vol. 32, Núm. 29